Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
about
Strategies to Overcome Heparins' Low Oral BioavailabilityPreparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug deliveryTrends in the development of oral anticoagulants.Stepwise inhibition of T cell recruitment at post-capillary venules by orally active desulfated heparins in inflammatory arthritisThe quest for non-invasive delivery of bioactive macromolecules: a focus on heparinsOral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levelsThiolated chitosans: useful excipients for oral drug delivery.Marine derived polysaccharides for biomedical applications: chemical modification approaches.Effect of various absorption enhancers based on tight junctions on the intestinal absorption of forsythoside A in Shuang-Huang-Lian, application to its antivirus activity.Advances in mucoadhesion and mucoadhesive polymers.Analysis of absorption enhancers in epithelial cell models.Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.Advances in oral macromolecular drug delivery.Recent advances in anticoagulant drug delivery.Preparation and optimization of N-trimethyl-O-carboxymethyl chitosan nanoparticles for delivery of low-molecular-weight heparin.Core shell methyl methacrylate chitosan nanoparticles: In vitro mucoadhesion and complement activation.Pellets for oral administration of low-molecular-weight heparin.Alkanoylsucroses in nasal delivery of low molecular weight heparins: in-vivo absorption and reversibility studies in rats.Enhanced ileal absorption of a hydrophilic macromolecule, pentosan polysulfate sodium (PPS).Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology.Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin.Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.In vitro and in vivo investigation of low molecular weight heparin-alginate beads for oral administration.Development of a carboxymethyl chitosan functionalized nanoemulsion formulation for increasing aqueous solubility, stability and skin permeability of astaxanthin using low-energy method.Physically cross-linked pH-responsive chitosan-based hydrogels with enhanced mechanical performance for controlled drug deliveryScientific potential of chitosan blending with different polymeric materials: A review
P2860
Q26745571-1AA941C8-A4B2-4F30-BDFF-81197F46BD59Q26766552-F1774B35-6FD2-476A-848F-1921DC5D2634Q33424198-BE447BA0-60D1-495E-AC4A-40FDE4A894F3Q33574588-E5261194-01D3-4509-9285-C8B147DBDAA8Q34976347-12A325F5-D346-4136-90A6-7D97F1CC7F87Q36012148-9DE4C003-8871-4E51-8501-F42CF9E401A4Q37088588-B09418D4-3102-4B3C-B457-B314CB658901Q37284597-6670239B-0162-4D22-AB8D-48F57ADB02AFQ37672176-35522356-33C8-45AC-B9A4-AA9F9BDED24BQ37824309-E0AD8254-33A1-46FF-8B2E-4016E9F856E5Q38021498-3526CFB1-A2F5-48CA-98E8-4E6AB2516A60Q38100561-2BD26FEE-B2FF-49AC-B868-00EBD42F30A3Q38235506-D7C0C512-C982-4DE1-A7A8-82F16D708E3FQ38649939-5F2E18B1-A4CD-4130-A144-273D43210D84Q38953388-54DFB093-BB4B-42D8-AC89-45E50A74CD41Q41877295-F729C929-9E30-49D6-820E-263825E297EAQ43237799-2AA38D96-C9C6-43D1-9807-134AB2D328B1Q44773923-8A86403E-4E96-41E4-A03C-8C30FE882ADBQ44986158-44F0A5AC-5A2C-4EDA-B2B7-B440A19D8BBCQ46343786-A7247036-E9F2-4DF5-8D4E-54F289582999Q46453303-5748630A-C153-41C2-BE9B-9E3D651CEC65Q46970819-304D6BC2-F4A3-4D5B-BB9E-A493C8E016FDQ47258578-E2DAE10C-7DCE-4DB2-8CF6-682A1C5F3776Q49991071-770B24D3-E105-4CCA-9906-E6973CD0ECFEQ57348205-D33D59D9-4F9F-459F-95C7-D7CA9DBA38BDQ57380963-2B9E2D00-C9C1-4A88-833D-7CAF98F619CC
P2860
Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Mono-N-carboxymethyl chitosan ...... pithelia in vitro and in vivo.
@ast
Mono-N-carboxymethyl chitosan ...... pithelia in vitro and in vivo.
@en
type
label
Mono-N-carboxymethyl chitosan ...... pithelia in vitro and in vivo.
@ast
Mono-N-carboxymethyl chitosan ...... pithelia in vitro and in vivo.
@en
prefLabel
Mono-N-carboxymethyl chitosan ...... pithelia in vitro and in vivo.
@ast
Mono-N-carboxymethyl chitosan ...... pithelia in vitro and in vivo.
@en
P2093
P1476
Mono-N-carboxymethyl chitosan ...... pithelia in vitro and in vivo.
@en
P2093
P356
10.1002/1520-6017(200101)90:1<38::AID-JPS5>3.0.CO;2-3
P407
P577
2001-01-01T00:00:00Z